Clinical Trials Browser

Phase 2/3 × HER2-positive Gastric Cancer × 90 days × Clear all

NCT07332533 2026-01-12

A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer

Phase 2/3 Not yet recruiting

Gastrointestinal

HER2-positive Gastric Cancer